其他品牌 品牌
代理商厂商性质
广州市所在地
ZAP-70抗原 Zeta链相关蛋白激酶70
广州健仑生物科技有限公司
该抗原是一种酪氨酸蛋白激酶,在T细胞和NK细胞中表达,参与T细胞受体的激活。该基因突变会使人类患重症复合性免疫缺陷综合症(SCID)。该抗原还与慢性淋巴细胞白血病(CLL)病人的Ig重链基因突变状态、病情进展和病人预后有关。所以该抗体可用于CLL的预后研究。
我司还提供其它进口或国产试剂盒:登革热、疟疾、流感、A链球菌、合胞病毒、腮病毒、乙脑、寨卡、黄热病、基孔肯雅热、克锥虫病、违禁品滥用、肺炎球菌、军团菌、化妆品检测、食品安全检测等试剂盒以及日本生研细菌分型诊断血清、德国SiFin诊断血清、丹麦SSI诊断血清等产品。
欢迎咨询
欢迎咨询
ZAP-70抗原 Zeta链相关蛋白激酶70
【产品介绍】
细胞定位:细胞浆
克隆号:2F3.2
同型:IgG
适用组织:石蜡/冰冻
阳性对照:慢性淋巴细胞白血病/扁桃体
抗原修复:热修复(EDTA)
抗体孵育时间:30-60min
产品编号 | 抗体名称 | 克隆型别 |
OB234 | T-bet(T盒子转录因子) | MRQ-46 |
OB235 | TCL1试剂(T细胞淋巴瘤1) | MRQ-7 |
OB236 | TdT(末端脱氧核苷酸转移酶) | polyclonal |
OB237 | TFE3试剂(转录因子E3) | MRQ-37 |
OB238 | Thyroglobulin(甲状腺球蛋白) | DAK-Tg6 |
OB239 | Thyroglobulin(甲状腺球蛋白) | 2H11+6E1 |
OB240 | TIA-1(T细胞胞浆内抗原) | 2G9A10F5 |
OB241 | Topo Ⅱ α(拓扑异构酶Ⅱα) | SD50 |
OB242 | TPO(甲状腺过氧化物酶) | AC25 |
OB243 | TS(胸苷酸合成酶) | TS106 |
OB244 | TSH 甲状腺刺激激素 | polyclonal |
OB245 | TTF-1(甲状腺转录因子1) | 8G7G3/1 |
OB246 | TTF-1(甲状腺转录因子1) | SPT24 |
OB247 | Tyrosinase(酪氨酸酶) | T311 |
OB248 | Uroplakin III试剂(尿溶蛋白III) | SP73 |
OB249 | VEGF(血管内皮生长因子) | VG1 |
OB250 | VEGF(血管内皮生长因子) | polyclonal |
OB251 | Villin(绒毛蛋白) | CWWB1 |
OB252 | Vimentin(波形蛋白) | V9 |
OB253 | Vimentin(波形蛋白) | SP20 |
OB254 | WT1(肾母细胞瘤) | EP122 |
OB255 | ZAP-70试剂() | 2F3.2 |
ZAP-70抗原
想了解更多的产品及服务请扫描下方二维码:
【公司名称】 广州健仑生物科技有限公司
【市场部】 欧
【】
【腾讯 】
【公司地址】 广州清华科技园创新基地番禺石楼镇创启路63号二期2幢101-103室
近年来,iPS研究发表的数量和速度都很惊人,但这些研究还局限于检测相对简单的系统。对于复杂网络引发的问题或疾病,就需要采用能描述网络互作的定量技术或者转基因动物模型。这些方面的进步将加深我们对重编程机制的理解,有助于早日实现人们对这一技术的期望。
美国亚利桑那州立大学宇宙学家Paul Davies和同事提出一个备受争议的结论,癌症是人体细胞试运转“安全模式”,如同计算机系统在面临外部威胁时试着保护自己那样。
宇宙学家提出疾病起源新理论
该理论主要基于癌症的进化,如果该理论正确,他们的模型提示,氧气治疗、感染病毒或细菌等一些非传统疗法可能尤其有效。
癌症是人体细胞试运转“安全模式”所产生的吗,就像受损计算机系统在面临外部威胁时试着保护自己那样?这是美国亚利桑那州立大学宇宙学家Paul Davies和同事得出的结论,他们提出了一个备受争议的癌症起源新理论。该理论主要基于癌症的进化根源。如果该理论正确,他们的模型提示,氧气治疗和感染病毒或细菌的一些非传统疗法可能尤其有效。
In recent years, the number and speed of iPS research publications have been staggering, but these studies have also been limited to the detection of relatively simple systems. For problems or diseases caused by complex networks, quantitative techniques or transgenic animal models that describe network interactions are needed. Advances in these areas will deepen our understanding of the reprogramming mechanism and help to bring about the early realization of this technology.
Paul Davies, an ASU cosmologist at the University of Arizona, and his colleagues came up with the most controversial conclusion that cancer is a "safe mode" of human cell testing, just as computer systems try to protect themselves in the face of external threats.
Cosmologists put forward a new theory of the origin of disease
The theory is based primarily on the evolution of cancer and if the theory is correct, their models suggest that some unconventional therapies such as oxygen therapy, infection with viruses or bacteria may be particularly effective.
Is cancer a "safe mode" of human cell commissioning, just as damaged computer systems try to protect themselves against external threats? This is the conclusion of cosmologist Paul Davies and colleagues at Arizona State University, They put forward a controversial new theory of cancer origin. The theory is based primarily on the evolutionary causes of cancer. If the theory is correct, their models suggest that oxygen therapy and some unconventional therapies that affect the virus or bacteria may be particularly effective.